FDA Investigator: Anna R. Kwilas
- Anna R. Kwilas first started conducting FDA inspections in 2022, with the last inspection in 2024. Over that time, Anna R. Kwilas has conducted 4 inspections at 4 companies across 4 sites.
Get Anna Kwilas's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Adaptimmune LLC, Philadelphia | 2024
Out-of-stock
Anna R. Kwilas
Biologics Form 483
FDA 483 Resilience US, Inc., Durham | 2024
Out-of-stock
Anna R. Kwilas
Biologics Form 483
FDA 483 Krystal Biotech, Inc., Pittsburgh | 2022
Out-of-stock
Anna R. Kwilas
Biologics Form 483
Co-Investigators (12)
- Viviana R. Ramirez, FDA Investigator
- Elvira R. Argus,
- Jie He, FDA Investigator
- Sharmila Shrestha, FDA Investigator
- Laura K. Demaster,
- Carl A. Perez, FDA Investigator
- Wei Wang, FDA Investigator
- Priscilla M. Pastrana, FDA Investigator
- Bo Liang, FDA Investigator
- Jianyang Wang, FDA Investigator
- Christian Lynch, FDA Investigator
- Jakob Reiser, FDA Investigator